| Year |
Citation |
Score |
| 2008 |
Nordan RP, Mock BA, Neckers LM, Rudikoff S. The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells. Annals of the New York Academy of Sciences. 557: 200-205. PMID 2786694 DOI: 10.1111/J.1749-6632.1989.Tb24013.X |
0.363 |
|
| 2006 |
Qiang Y, Chen Y, Stephens O, Rubin J, Rudikoff S, Barlogie B, Shaughnessy JD. On the Molecular Mechanism of DKK1 Inhibition of Osteoblast Differentiation in Multiple Myeloma. Blood. 108: 3429-3429. DOI: 10.1182/Blood.V108.11.3429.3429 |
0.332 |
|
| 2005 |
Qiang YW, Walsh K, Yao L, Kedei N, Blumberg PM, Rubin JS, Shaughnessy J, Rudikoff S. Wnts induce migration and invasion of myeloma plasma cells. Blood. 106: 1786-93. PMID 15886323 DOI: 10.1182/Blood-2005-01-0049 |
0.32 |
|
| 2005 |
Crowder C, Dahle Ø, Davis RE, Gabrielsen OS, Rudikoff S. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction. Blood. 105: 1280-7. PMID 15459016 DOI: 10.1182/Blood-2004-04-1614 |
0.305 |
|
| 2004 |
Qiang YW, Yao L, Tosato G, Rudikoff S. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood. 103: 301-8. PMID 14504085 DOI: 10.1182/Blood-2003-06-2066 |
0.306 |
|
| 2003 |
Qiang YW, Endo Y, Rubin JS, Rudikoff S. Wnt signaling in B-cell neoplasia. Oncogene. 22: 1536-45. PMID 12629517 DOI: 10.1038/Sj.Onc.1206239 |
0.309 |
|
| 2000 |
Ge NL, Rudikoff S. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo Oncogene. 19: 4091-4095. PMID 10962569 DOI: 10.1038/Sj.Onc.1203801 |
0.317 |
|
| 2000 |
Ge N, Rudikoff S. Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood. 96: 2856-2861. DOI: 10.1182/Blood.V96.8.2856.H8002856_2856_2861 |
0.301 |
|
| 1999 |
Swaminathan N, Lopez-Berestein G, Rudikoff S. Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia. Medical Oncology (Northwood, London, England). 16: 119-28. PMID 10456660 DOI: 10.1007/Bf02785845 |
0.313 |
|
| 1998 |
Kopantzev E, Roschke V, Rudikoff S. Interleukin-2-Mediated Modulation of Plasma Cell Tumor Growth in a Model of Multiple Myeloma Human Gene Therapy. 9: 13-19. PMID 9458238 DOI: 10.1089/Hum.1998.9.1-13 |
0.327 |
|
| 1997 |
Pumphrey JG, Hausner P, Rudikoff S. Characterization of C57BL/6 plasmacytomas lacking a c-myc translocation. International Journal of Cancer. 72: 892-897. PMID 9311610 DOI: 10.1002/(Sici)1097-0215(19970904)72:5<892::Aid-Ijc29>3.0.Co;2-9 |
0.303 |
|
| 1996 |
Hilbert DM, Migone TS, Kopf M, Leonard WJ, Rudikoff S. Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity. 5: 81-9. PMID 8758897 DOI: 10.1016/S1074-7613(00)80312-X |
0.317 |
|
| 1996 |
Howcroft TK, Weissman JD, Rudikoff S, Frels WI, Singer DS. Repression of the nonclassical MHC class I gene H2-M1 by cis-acting silencer DNA elements. Immunogenetics. 44: 268-74. PMID 8753857 DOI: 10.1007/Bf02602556 |
0.319 |
|
| 1995 |
Hilbert DM, Shen MY, Rapp UR, Rudikoff S. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proceedings of the National Academy of Sciences of the United States of America. 92: 649-53. PMID 7846031 DOI: 10.1073/Pnas.92.3.649 |
0.332 |
|
| 1995 |
Hilbert DM, Kopf M, Mock BA, Köhler G, Rudikoff S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. The Journal of Experimental Medicine. 182: 243-8. PMID 7790819 DOI: 10.1084/Jem.182.1.243 |
0.312 |
|
| 1993 |
Henderson TJ, Rudikoff S. Characterization of a Vκ family in Mus musculus castaneus: sequence analysis Immunogenetics. 37: 426-436. PMID 8436417 DOI: 10.1007/Bf00222466 |
0.309 |
|
| 1991 |
Shin SU, DePinho R, Zack DJ, Rudikoff S, Scharff MD. Instability of immunoglobulin genes in S107 cell line. Somatic Cell and Molecular Genetics. 17: 259-76. PMID 1904631 DOI: 10.1007/Bf01232821 |
0.337 |
|
| 1989 |
Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells Proceedings of the National Academy of Sciences of the United States of America. 86: 802-806. PMID 2915979 DOI: 10.1073/Pnas.86.3.802 |
0.344 |
|
| 1988 |
Suh SW, Bhat TN, Navia MA, Cohen GH, Rao DN, Rudikoff S, Davies DR. The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution. Proteins. 1: 74-80. PMID 3449853 DOI: 10.1002/Prot.340010112 |
0.323 |
|
| 1988 |
Singer DS, Hare J, Golding H, Flaherty L, Rudikoff S. Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. Immunogenetics. 28: 13-21. PMID 3378834 DOI: 10.1007/Bf00372524 |
0.324 |
|
| 1986 |
Jouvin-Marche E, Heller M, Rudikoff S. Gene correction in the evolution of the T cell receptor beta chain. Journal of Experimental Medicine. 164: 2083-2088. PMID 3783089 DOI: 10.1084/Jem.164.6.2083 |
0.314 |
|
| 1986 |
Smith-Gill SJ, Hamel PA, Klein MH, Rudikoff S, Dorrington KJ. Contribution of the VK4 light chain to antibody specificity for lysozyme and β(1,6)d-galactan Molecular Immunology. 23: 919-926. PMID 3097519 DOI: 10.1016/0161-5890(86)90121-5 |
0.373 |
|
| 1986 |
Rudikoff S, Pumphrey JG. Functional antibody lacking a variable-region disulfide bridge. Proceedings of the National Academy of Sciences of the United States of America. 83: 7875-7878. PMID 3094016 DOI: 10.1073/Pnas.83.20.7875 |
0.375 |
|
| 1986 |
Jouvin-Marche E, Rudikoff S. Evolution of a V κ gene family Immunogenetics. 24: 191-201. PMID 3093373 DOI: 10.1007/Bf00364748 |
0.339 |
|
| 1985 |
Greene WC, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Krönke M, Svetlik P, Peffer NJ, Waldmann TA. Molecular cloning of cDNA for the human interleukin-2 receptor. Haematology and Blood Transfusion. 29: 388-95. PMID 2993133 DOI: 10.1007/978-3-642-70385-0_80 |
0.32 |
|
| 1984 |
Rudikoff S, Pawlita M, Mushinski E, Pumphrey J, Potter M. Characterization of idiotypes on antibodies to galactan Annales De L'Institut Pasteur. Immunologie. 135: 89-94. PMID 6712165 DOI: 10.1016/S0769-2625(84)80017-3 |
0.313 |
|
| 1984 |
Rudikoff S, Pawlita M, Pumphrey J, Heller M. Somatic diversification of immunoglobulins Proceedings of the National Academy of Sciences of the United States of America. 81: 2162-2166. PMID 6425827 DOI: 10.1073/Pnas.81.7.2162 |
0.374 |
|
| 1984 |
Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, Krönke M, Svetlik PB, Peffer NJ, Waldmann TA. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature. 311: 626-31. PMID 6090948 DOI: 10.1038/311626A0 |
0.33 |
|
| 1983 |
Rudikoff S, Pawlita M, Pumphrey J, Mushinski E, Potter M. Galactan-binding antibodies. Diversity and structure of idiotypes. Journal of Experimental Medicine. 158: 1385-1400. PMID 6195282 DOI: 10.1084/Jem.158.5.1385 |
0.359 |
|
| 1982 |
Rudikoff S, Giusti AM, Cook WD, Scharff MD. Single amino acid substitution altering antigen-binding specificity. Proceedings of the National Academy of Sciences of the United States of America. 79: 1979-83. PMID 6804947 DOI: 10.1073/Pnas.79.6.1979 |
0.375 |
|
| 1982 |
Cook WD, Rudikoff S, Giusti AM, Scharff MD. Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proceedings of the National Academy of Sciences of the United States of America. 79: 1240-4. PMID 6803237 DOI: 10.1073/Pnas.79.4.1240 |
0.408 |
|
| 1982 |
Rudikoff S, Satow Y, Padlan E, Davies D, Potter M. Kappa chain structure from a crystallized murine Fab': role of joining segment in hapten binding. Molecular Immunology. 18: 705-11. PMID 6796825 DOI: 10.1016/0161-5890(81)90062-6 |
0.402 |
|
| 1981 |
Kwan SP, Rudikoff S, Seidman JG, Leder P, Scharff MD. Nucleic acid and protein sequences of phosphocholine-binding light chains. The Journal of Experimental Medicine. 153: 1366-70. PMID 6788890 DOI: 10.1084/Jem.153.5.1366 |
0.368 |
|
| 1980 |
Rudikoff S, Rao DN, Glaudemans CP, Potter M. kappa Chain joining segments and structural diversity of antibody combining sites Proceedings of the National Academy of Sciences of the United States of America. 77: 4270-4274. PMID 6776525 DOI: 10.1073/Pnas.77.7.4270 |
0.395 |
|
| 1978 |
Vrana M, Rudikoff S, Potter M. Sequence variation among heavy chains from inulin-binding myeloma proteins Proceedings of the National Academy of Sciences of the United States of America. 75: 1957-1961. PMID 417344 DOI: 10.1073/Pnas.75.4.1957 |
0.416 |
|
| 1978 |
Rudikoff S, Potter M. kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein. Biochemistry. 17: 2703-2707. PMID 99160 DOI: 10.1021/Bi00607A001 |
0.36 |
|
| 1977 |
Padlan EA, Davies DR, Rudikoff S, Potter M. Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry. 13: 945-9. PMID 827496 DOI: 10.1016/0019-2791(76)90239-1 |
0.388 |
|
| 1977 |
Vrana M, Rudikoff S, Potter M. Heavy-chain variable-region sequence from an inulin-binding myeloma protein. Biochemistry. 16: 1170-1175. PMID 402936 DOI: 10.1021/Bi00625A022 |
0.383 |
|
| 1975 |
Segal DM, Padlan EA, Cohen GH, Rudikoff S, Potter M, Davies DR. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proceedings of the National Academy of Sciences of the United States of America. 71: 4298-302. PMID 4530984 DOI: 10.1073/Pnas.71.11.4298 |
0.372 |
|
| 1975 |
Riesen W, Rudikoff S, Oriol R, Potter M. An IgM Waldenström with specificity against phosphorylcholine. Biochemistry. 14: 1052-1057. PMID 804915 DOI: 10.1021/Bi00676A026 |
0.38 |
|
| 1974 |
Rudikoff S, Potter M. Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein. Biochemistry. 13: 4033-4038. PMID 4213527 DOI: 10.1021/Bi00716A034 |
0.384 |
|
| 1974 |
Barstad P, Rudikoff S, Potter M, Cohn M, Konigsberg W, Hood L. Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (New York, N.Y.). 183: 962-6. PMID 4129807 DOI: 10.1126/Science.183.4128.962 |
0.398 |
|
| 1973 |
Jolley ME, Rudikoff S, Potter M, Glaudemans CPJ. Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins Biochemistry. 12: 3039-3044. PMID 4581145 DOI: 10.1021/Bi00740A015 |
0.323 |
|
| 1973 |
Padlan EA, Segal DM, Spande TF, Davies DR, Rudikoff S, Potter M. Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nature: New Biology. 245: 165-7. PMID 4517781 DOI: 10.1038/Newbio245165A0 |
0.31 |
|
| 1973 |
Rudikoff S, Mushinski EB, Potter M, Glaudemans CPJ, Jolley ME. SIX BALB/c IgA MYELOMA PROTEINS THAT BIND ß-(1 → 6)-D-GALACTAN PARTIAL AMINO ACID SEQUENCES AND IDIOTYPES Journal of Experimental Medicine. 138: 1095-1106. PMID 4126765 DOI: 10.1084/Jem.138.5.1095 |
0.393 |
|
| 1973 |
Jolley M, Rudikoff S, Potter M, Glaudermans CP. Correction - Spectral Changes on Binding of Oligosaccharides to Murine Immunoglobulin A Myeloma Proteins Biochemistry. 12: 5224-5224. DOI: 10.1021/Bi00749A603 |
0.32 |
|
| Show low-probability matches. |